Dechra Pharmaceuticals PLC
18 May 2006
Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: Thursday 18th May 2006
Immediate Release
Dechra Pharmaceuticals PLC
('Dechra' or 'the Company')
Notice of Extraordinary General Meeting
The Company announces that it has today lodged with the FSA viewing facility, a
circular incorporating notice of an Extraordinary General Meeting to be held on
2nd June 2006 for the purpose of obtaining shareholder approval in respect of
extending the authorisation period for issuing employee share options from five
to ten years from adoption of the schemes.
The EGM will be held at 9.00am at Dechra House, Jamage Industrial Estate, Talke
Pits, Stoke on Trent, Staffordshire ST7 1XW.
The circular is available for inspection at the UK listing Authority's Document
Viewing Facility which is situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
Enquiries
Steve Whitehouse, Company Secretary Katie Dale, Senior Account Manager
Dechra Pharmaceuticals PLC Citigate Dewe Rogerson
Tel: 01743 441 632 Tel: 0121 455 8370
Mobile: 07770 788 624
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.